Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|June 2, 2023
Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198)Walid L Shaib, Rupji Manali, Yuan Liu, et al.Journal of Cachexia, Sarcopenia and Muscle|July 10, 2019
The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapyXiaoling Zhong, Marianne Pons, Christophe Poirier, et al.International Journal of Radiation Oncology, Biology, Physics|April 15, 2014
Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancerE Gabriela Chiorean, Bryan P Schneider, Fatih M Akisik, et al.Future Oncology (London, England)|February 16, 2019
CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabineMohamad Bassam Sonbol, Daniel H Ahn, David Goldstein, et al.The Oncologist|February 7, 2024
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular CarcinomaShawn Yu, Menggang Yu, Barry Keane, et al.The Oncologist|December 22, 2025
A Phase I study targeting the APE1/ref-1 redox signaling protein with APX3330: First clinical agent targeting APE1/ref-1 in CancerMark R Kelley, Jun Wan, Sheng Liu, et al.Investigational New Drugs|May 18, 2026
Preclinical and clinical evaluation of futibatinib in combination with binimetinib in patients with advanced cancerJordi Rodon, Bert O'Neil, Christopher Lim, et al.The New England Journal of Medicine|September 26, 2025
Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with PolyneuropathyJulian D Gillmore, Ed Gane, Jörg Täubel, et al.Cancer Chemotherapy and Pharmacology|November 22, 2017
The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancerGrant R Williams, Allison M Deal, Shlomit Strulov Shachar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2017
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 TrialJean-Sebastien Frenel, Christophe Le Tourneau, Bert O'Neil, et al.Pageof 7